Fish Oil vs Omega-3: What's the Difference?

Fish oil is a source of omega-3s, not a rival to them. It supplies two long-chain omega-3s, EPA and DHA¹. Compare products by their EPA plus DHA content: a typical capsule holds about 180 mg EPA and 120 mg DHA per 1,000 mg of oil².

Krill oil, cod liver oil, algal oil and plant oils are the other omega-3 options³. Our omega-3 evidence page covers benefits and dosing in depth. This comparison covers how the sources differ and when each makes sense.

No. Omega-3s are a family of fats, and fish oil is one supplement that delivers two of them¹. Researchers study three omega-3s most²:

• ALA (alpha-linolenic acid): an 18-carbon plant omega-3 found in flaxseed, soybean and canola oils².
• EPA (eicosapentaenoic acid): a 20-carbon long-chain omega-3 found in fish and other seafood^{2, 3}.
• DHA (docosahexaenoic acid): a 22-carbon long-chain omega-3, especially concentrated in the retina, brain and sperm cells^{2, 3}.

Fish do not make EPA and DHA themselves. Microalgae make them first, and fish accumulate them up the food chain². That is why algal oil can supply the same fats without fish.

The label therefore matters more than the words "fish oil". Formulations vary widely, so read the types and amounts of omega-3s on each product².

All of these count as omega-3 supplements³. They differ in which omega-3s they carry and what comes with them²:

• Fish oil: EPA and DHA mostly as natural triglycerides, the form found in fish².
• Krill oil: omega-3s mainly as phospholipids. Some studies find slightly better absorption than fish oil and others do not².
• Cod liver oil: adds vitamin A and vitamin D to the omega-3s².
• Algal oil: a vegetarian source, usually 100 to 300 mg DHA per serving and sometimes with EPA².
• Flaxseed and other plant oils: ALA only².

For the krill question in detail, see our krill oil vs fish oil comparison and the krill oil evidence page.

Cod liver oil vs fish oil

Cod liver oil supplements provide vitamin A and vitamin D in addition to the omega-3s². That is the main trade-off. The upper limit for preformed vitamin A is 3,000 mcg a day for adults and 2,800 mcg for ages 14 to 18, including in pregnancy, because higher intakes are linked to liver abnormalities, birth defects and toxicity in children⁴.

If you take cod liver oil alongside a multivitamin, add up the vitamin A from both labels.

Supplements in this guide

• Krill Oil
• Flaxseed Oil

Only in part. Your body can convert some ALA into EPA and then DHA, but the rate is limited, with reported figures under 15%². A review of human studies put conversion at about 5% for EPA and under 0.5% for DHA⁵. NIH therefore calls direct EPA and DHA intake the only practical way to raise them².

Conversion is not zero. In a 12-week trial of 62 firefighters, 2.4 or 3.6 g of flaxseed oil a day raised red blood cell ALA, EPA and docosapentaenoic acid. Fish oil produced a rapid rise in red blood cell DHA⁶.

ALA still has value of its own. NIH sets recommended intakes of 1.6 g a day for men and 1.1 g for women, and most people in the United States meet them through food³. In a Cochrane review, extra ALA made little or no difference to all-cause mortality (RR 1.01). It probably cut arrhythmia risk slightly (RR 0.73, 2 trials, moderate certainty)⁷.

Plant sources include flaxseed, chia seeds and walnuts³. They are worth eating, but they do not replace EPA and DHA from fish or algae.

Algal oil is the practical answer. It carries the same EPA and DHA that fish store², and two randomized trials support it:

• In 32 adults, 600 mg a day of DHA from algal-oil capsules and from cooked salmon raised DHA by about 80% in plasma phospholipids and 25% in red blood cells, with similar changes in both groups⁸.
• In 74 adults, microalgal oil was statistically non-inferior to fish oil for DHA and EPA in plasma phospholipids at 6 and 14 weeks⁹.

Both trials were short and measured blood levels, not heart or brain outcomes. Algal supplements usually give 100 to 300 mg DHA, so check the label for the EPA plus DHA you actually get².

For raising blood levels, one small trial says yes at matched doses. Healthy premenopausal women (11 in the fish group) ate 2 servings of oily fish a week or took capsules, both averaging 485 mg EPA plus DHA a day. After 16 weeks their red blood cell EPA plus DHA reached 6.2% of fatty acids in each group¹⁰.

For blood lipids, one trial favored fish. In 106 adults with high blood lipids, 250 g of trout twice a week beat 2 g a day of omega-3 capsules over 8 weeks for total cholesterol, triglycerides and HDL. LDL cholesterol fell with fish but rose with capsules¹¹. The trial was open-label, so participants knew which arm they were in.

NIH adds a caution. People who eat fish have lower risks of several chronic diseases, but it is unclear whether the benefit comes from the omega-3s or from the foods themselves³. The American Heart Association recommends one to two servings of seafood a week³.

A little, though probably not enough to drive what you buy. Supplements come as natural triglycerides, ethyl esters, re-esterified triglycerides, free fatty acids or phospholipids. All raise blood EPA and DHA significantly².

In 72 volunteers taking about 3.3 g EPA plus DHA daily for 2 weeks, absorption from re-esterified triglycerides was 124% of natural fish oil. Free fatty acids reached 91% and ethyl esters 73%¹². A 2025 review ranked absorption as free fatty acids, then phospholipids, re-esterified triglycerides, natural triglycerides and ethyl esters. It found that acute differences often did not carry into long-term supplementation¹³. A trial in healthy adults likewise found lipid structure did not change most blood measures¹⁴.

Dose per capsule matters more than form.

Large trials of everyday omega-3 supplements are mostly disappointing, while a high-dose purified EPA product helped people with high triglycerides^{7, 15}:

• Cochrane review, 2020: 86 trials and 162,796 participants found little or no effect of long-chain omega-3s on all-cause mortality (RR 0.97) or cardiovascular events (RR 0.96), both high-certainty⁷.
• VITAL: 1 g a day of marine omega-3 (460 mg EPA plus 380 mg DHA) in 25,871 adults without prior heart disease did not significantly cut major cardiovascular events (HR 0.92, 95% CI 0.80 to 1.06) over a median 5.3 years. Heart attacks were fewer, a secondary result (HR 0.72)^{16, 2}.
• REDUCE-IT: 4 g a day of purified EPA ethyl ester in 8,179 statin-treated patients with high triglycerides cut major events from 22.0% to 17.2% (HR 0.75), though hospitalization for AF or flutter was higher (3.1% vs 2.1%)¹⁵.
• STRENGTH: 4 g a day of an EPA plus DHA formulation against corn oil in 13,078 high-risk patients showed no difference, 12.0% vs 12.2% (HR 0.99)¹⁷.

These trials used different products, doses and comparators, so their results are not directly comparable. NIH notes the placebos differed too, mineral oil in REDUCE-IT and corn oil in STRENGTH, which may partly explain the conflicting results². Mayo Clinic's summary is that supplements seem to have little to no heart benefit, while eating fish at least twice a week is linked to lower heart-disease death¹. See heart health and cardiovascular disease for the wider evidence.

Is fish oil or omega-3 better for cholesterol and triglycerides?

Triglycerides are where the evidence is firmest, and "fish oil" and "omega-3" give the same result because EPA and DHA do the work. Long-chain omega-3s lowered triglycerides by about 15% in a dose-dependent way (high-certainty evidence), with little or no effect on other lipids⁷.

The American Heart Association concludes that 4 g a day of prescription omega-3s lowers triglycerides. An analysis of 58 trials found each extra 1 g a day cut triglycerides by 5.9 mg/dL, more in people starting higher². Mayo Clinic notes a slight HDL rise but also an LDL rise in some studies¹. Our pages on omega-3 for high cholesterol and triglyceride reduction go deeper.

Again they are the same thing, and the evidence is mixed. A 2014 meta-analysis of 68 trials in 4,601 people found marine omega-3s lowered CRP, IL-6 and TNF-α, including in healthy subjects. In people with chronic non-autoimmune disease the effect weakened when BMI was above 30¹⁸.

In 261 healthy adults, 1,400 mg a day of EPA plus DHA for 18 weeks raised red blood cell EPA plus DHA by 64% but left CRP and IL-6 unchanged¹⁹. The bottom line: pooled trials show small drops in inflammation markers, while a well-controlled trial in healthy adults showed none.

For joints, Mayo Clinic reports that fish oil might reduce pain, morning stiffness and tenderness in rheumatoid arthritis, though relief is often modest¹. NIH says people with RA who take omega-3s may need less pain medication, but it is not clear the supplements reduce joint pain, swelling or morning stiffness³. See omega-3 for inflammation and omega-3 for rheumatoid arthritis.

Probably not. NIH names ALA, an omega-3, and linoleic acid, an omega-6, as the essential fatty acids². Omega-9 fats are not on that list.

No optimal omega-6 to omega-3 ratio has been defined. Most researchers agree that raising EPA and DHA levels matters far more than lowering omega-6 levels². US adults average only about 90 mg a day of EPA plus DHA from food, while most meet recommended ALA intakes². A blend that adds omega-6 and omega-9 does not fill that gap.

Side effects are usually mild: an unpleasant taste, bad breath, heartburn, nausea, stomach discomfort, diarrhea, headache and smelly sweat³. Mayo Clinic also lists rash¹.

The larger signal is atrial fibrillation (AF), an irregular heart rhythm. A meta-analysis of 7 cardiovascular outcome trials in 81,210 patients, mean age 65, linked marine omega-3 supplements to higher AF risk (HR 1.25, 95% CI 1.07 to 1.46). Risk was raised at 1 g a day or less (HR 1.12, 95% CI 1.03 to 1.22) and was larger above 1 g (HR 1.49, 95% CI 1.04 to 2.15)²⁰.

Bleeding is the other concern at high doses. Mayo Clinic says high doses might raise bleeding risk and possibly stroke risk, that too much might affect the immune response, and that fish oil should be taken under a doctor's supervision¹. FDA advises no more than 5 g a day of EPA plus DHA combined from supplements³.

Ask a clinician or pharmacist first if any of these apply¹:

• Blood thinners and antiplatelet drugs: fish oil might add to the bleeding risk¹. Most research finds 3 to 6 g a day of fish oil does not significantly change anticoagulation in people on warfarin, but package inserts advise periodic INR checks². See our guide to blood thinners and supplements.
• Blood pressure medicines: fish oil may lower blood pressure slightly, adding to the drugs' effect¹.
• Orlistat: it may reduce absorption of fish oil fatty acids, so Mayo Clinic suggests taking them 2 hours apart¹.
• Contraceptive drugs: some may interfere with fish oil's triglyceride effect¹.
• Vitamin E: fish oil can lower vitamin E levels¹.
• Seafood allergy: it is not clear whether fish oil is safe¹.

In pregnancy, NIH recommends 8 to 12 ounces of seafood a week and notes that it is unclear whether EPA and DHA supplements affect a baby's health³.

Yes, they have been tested together. VITAL randomized 25,871 adults to 2,000 IU a day of vitamin D3, 1 g a day of omega-3, both, or placebo. It found no excess bleeding or other serious adverse events with omega-3¹⁶.

You can get adequate omega-3s from a varied diet³. NIH lists these foods³:

• Fish and seafood: especially salmon, mackerel, tuna, herring and sardines.
• Nuts and seeds: flaxseed, chia seeds and walnuts.
• Plant oils: flaxseed, soybean and canola oils.
• Fortified foods: certain eggs, yogurts, juices, milks and soy beverages.

Fish supply EPA and DHA. Nuts, seeds and plant oils supply ALA³.

True deficiency is rare in the United States. It causes rough, scaly skin and a red, swollen, itchy rash³. Clinical signs have mostly been seen in patients fed by vein with solutions that lacked fats².

Low intake is more common than deficiency. No cut-off EPA or DHA level is known to impair function². A blood test can estimate your status: plasma phospholipid EPA plus DHA averages about 3% to 4% in US adults who do not take supplements². Most clinicians do not order it routinely².

Match the source to your situation:

• You eat oily fish once or twice a week: that meets the American Heart Association's seafood advice. The AHA does not recommend omega-3 supplements for people who are not at high risk of heart disease³.
• You eat little fish and want EPA and DHA: choose a fish oil by the EPA plus DHA per serving, since doses vary widely².
• You avoid animal products: choose algal oil, which matched fish oil and cooked salmon in the trials above^{8, 9}.
• You have heart disease: the AHA suggests about 1 g a day of EPA plus DHA, preferably from oily fish, with supplements an option under a clinician's guidance³.
• You have high triglycerides: the 4 g a day prescription dose is a medical decision².

FDA's upper limit is 5 g a day of EPA plus DHA from supplements³, but AF risk was higher above 1 g a day in trials²⁰, so use high doses only with a clinician. For timing, see when to take fish oil.

We searched PubMed-indexed literature, plus NIH Office of Dietary Supplements fact sheets and Mayo Clinic, on 2 November 2026. We read the abstracts of 16 journal records and 4 web pages, and cited all of them.

We prioritized systematic reviews, large randomized trials and head-to-head bioavailability trials in adults. For journal sources we read abstracts, not full texts. The evidence cannot yet say whether the small bioavailability differences between forms change health outcomes. Several omega-3 trials tested different products at different doses, so their results do not combine neatly.

1. Mayo Clinic Staff. Fish oil. Mayo Clinic; updated January 21, 2026. https://www.mayoclinic.org/drugs-supplements-fish-oil/art-20364810
2. National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/
3. National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Consumers. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer/
4. National Institutes of Health, Office of Dietary Supplements. Vitamin A and Carotenoids: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
5. Plourde M, et al. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab. 2007;32(4):619-34. doi:10.1139/H07-034
6. Barceló-Coblijn G, et al. Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. Am J Clin Nutr. 2008;88(3):801-9. doi:10.1093/ajcn/88.3.801
7. Abdelhamid AS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3):CD003177. doi:10.1002/14651858.CD003177.pub5 Our study summary.
8. Arterburn LM, et al. Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid. J Am Diet Assoc. 2008;108(7):1204-9. doi:10.1016/j.jada.2008.04.020
9. Bailey E, et al. Comparative Bioavailability of DHA and EPA from Microalgal and Fish Oil in Adults. Int J Mol Sci. 2025;26(19). doi:10.3390/ijms26199343
10. Harris WS, et al. Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. Am J Clin Nutr. 2007;86(6):1621-5. doi:10.1093/ajcn/86.5.1621
11. Zibaeenezhad MJ, et al. Comparison of the effect of omega-3 supplements and fresh fish on lipid profile: a randomized, open-labeled trial. Nutr Diabetes. 2017;7(12):1. doi:10.1038/s41387-017-0007-8
12. Dyerberg J, et al. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids. 2010;83(3):137-41. doi:10.1016/j.plefa.2010.06.007
13. Alijani S, et al. Bioavailability of EPA and DHA in humans - A comprehensive review. Prog Lipid Res. 2025;97:101318. doi:10.1016/j.plipres.2024.101318
14. West AL, et al. Lipid structure does not modify incorporation of EPA and DHA into blood lipids in healthy adults: a randomised-controlled trial. Br J Nutr. 2016;116(5):788-97. doi:10.1017/S0007114516002713
15. Bhatt DL, et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11-22. doi:10.1056/NEJMoa1812792 Our study summary.
16. Manson JE, et al. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med. 2019;380(1):23-32. doi:10.1056/NEJMoa1811403 Our study summary.
17. Nicholls SJ, et al. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. JAMA. 2020;324(22):2268-2280. doi:10.1001/jama.2020.22258 Our study summary.
18. Li K, et al. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis. PLoS One. 2014;9(2):e88103. doi:10.1371/journal.pone.0088103
19. Muldoon MF, et al. Fish oil supplementation does not lower C-reactive protein or interleukin-6 levels in healthy adults. J Intern Med. 2016;279(1):98-109. doi:10.1111/joim.12442
20. Gencer B, et al. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation. 2021;144(25):1981-1990. doi:10.1161/CIRCULATIONAHA.121.055654 Our study summary.